ORAOV1 Polyclonal Antibody

Alias:ORAOV1;TAOS1;Oral cancer-overexpressed protein 1;Tumor-amplified and overexpressed sequence 1

CatalogNo:HJRLT3468

Specifications

50μL;100μL

Delivery date

Spot

Target

ORAOV1

Reactivity

Human,Mouse

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

15kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human ORAV1. AA range:81-130

Specificity

ORAOV1 Polyclonal Antibody detects endogenous levels of ORAOV1 protein.

Gene name

ORAOV1

Protein name

Oral cancer-overexpressed protein 1

Organism-1

Human